An expert in pediatric rheumatology, Karen Onel, MD, cares for children and teens with arthritis and other autoimmune disorders. In particular, she diagnoses and treats: lupus, juvenile arthritis, vasculitis, uveitis (an inflammatory disorder of the eye), chronic non-infectious osteomyelitis, dermatomyositis and the periodic fever syndromes. Her goal is to work with the patient and his/her family to create a long-term care plan that will lead to improved quality of life.
Dr. Onel's research focuses on gaining a greater understanding of the causes of rheumatic illnesses, as well as evaluating the safety and tolerability of new treatments. She is collaborating with other institutions to define evidence-based best treatment practices for children with JIA, SLE and recurrent non-infectious osteomyelitis.
Dr. Onel has authored numerous papers, reviews and book chapters on pediatric rheumatology. In addition, she serves as a reviewer for many scientific journals, is on the editorial board of Pediatric Rheumatology and is Associate Editor for Seminars in Arthritis and Rheumatism.
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Chief, Pediatric Rheumatology, Hospital for Special Surgery
Attending Physician, Hospital for Special Surgery
Castle Connolly Top Doctor, 10 Years
Castle Connolly America's Top Doctors, 2014-2021
Castle Connolly Top Doctors in New York Metro Area, 2018-2022
New York Magazine Top Doctors, 2018-2022
Chicago Magazine Top Doctors, 2012, 2014, 2016
Amgen Pediatric Rheumatology Visiting Professorship, 2014, 2015
Chicago Arthritis Walk Medical Honoree, 2013
ACR Pediatric Rheumatology Research Award, 1994
Fellowship ACR Senior Rheumatology Scholar Award, 1994
Mitchell Spivak Memorial Prize in Pediatrics, 1989
Janet M. Glasgow Memorial Achievement Citation, 1989
Alpha Omega Alpha, 1988
Cornell University Medical College, New York
Columbia Presbyterian Medical Center, New York
Columbia Presbyterian Medical Center, New York
Hospital for Special Surgery, New York
JIA in the 21st Century.” Pediatric Grand Rounds, NYP Brooklyn Methodist Hospital, 2019
Challenges in Juvenile Arthritis. Pediatric Rheumatology: An Update for Clinicians, NYU, New York, March, 13 2019
When aches and pains are more than aches and pains. NYC Department of Health and Mental Health, Office of School Health Physicians, New York, NY, December 18, 2019
2020 ACR Guideline for the Treatment of JIA:
Therapeutic Approaches for Oligoarthritis, TMJ Arthritis, and Systemic JIA, Medication Monitoring, Immunizations and Non-Pharmacologic Therapies.” ACR Convergence, Annual Scientific Meeting of the American College of Rheumatology.” Atlanta, Ga.. November, 2020
Therapeutic Approaches for Oligoarthritis, TMJ Arthritis, and SystemicJIA,Medication Monitoring, Immunizations and Non-Pharmacologic Therapies.” The best of ACR Convergence. Riyadh, Saudi Arabia, 2020
Therapeutic Approaches for Oligoarthritis, TMJ Arthritis, and SystemicJIA,Medication Monitoring, Immunizations and Non-Pharmacologic Therapies.” The best of ACR Convergence. Beijing, China, 2021
How much conflict is too much. Pediatric Grand Rounds, Rheumatology Grand Rounds Hospital for Special Surgery, January, 2021
How much conflict is too much. Pediatric Grand Rounds, University of Chicago Medicine, Chicago, IL, 2021
Systemic JIA. Pediatric Rheumatology Grand Rounds, Riley Children’s Hospital, Indianapolis, IN, 2021
Covid in childhood. State of the Art, American College of Rheumatology, April 11, 2021
How I learned to love this topic (COI). Pediatric Professors Rounds, Weill Cornell Pediatrics New York, July 9, 2021
Ethics of biobanking & genetic research in Pediatric Rheumatology. ACR Convergence Annual Scientific Meeting of the American College of Rheumatology. San Francisco, Ca, November 7, 2021
Current interests include:
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
Below are the healthcare industry relationships reported by Dr. Onel as of September 20, 2019.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.